Background/Aims: Increasing evidences indicated the important roles of alternative most previous research has focused on one or several alternative splicing events, without a comprehensive evaluation of the prognostic value of splicing events in BLCA. In this study, we aimed to determine risk scores for predicting prognosis of BLCA patients based on splicing events. Methods: downloaded from The Cancer Genome Atlas, and data of splicing events were obtained from the to identify survival-associated alternative spicing events (SASEs) and to calculate risk scores. Protein-protein interaction analysis of genes of the SASEs was performed using STRING, a database of known and predicted protein-protein interactions, and pathway enrichment analysis of the genes was implemented using the Database for Annotation, Visualization and Integrated Discovery (version 6.8 potential regulatory network with SASEs of splicing factors and other genes was constructed, which might be part of the biological mechanisms associated with prognosis of BLCA patients.
Introduction
Proteins are a class of biomacromolecules and are the main constituents of cells and tissues, playing crucial roles in many vital activities. Protein species diversity is the basis intronic or exonic regions are removed from precursor mRNA, and the multiple combinations achieved by splicing exons together to produce mature RNAs is an important source of protein species diversity [1] [2] [3] [4] . Thus, changes in alternative splicing patterns may lead to changes in protein functions and the vital activities based on these functions. and tumor occurrence [5] . Alternative splicing has been participated in the mechanisms of tumorigenesis and progression, especially invasion and metastasis of tumor cells [6] [7] [8] [9] . In addition, alternative splicing events might serve as biomarkers for cancer diagnosis and treatment, and as potential targets for drug discovery [10] .
Splicing factors are the executors of the splicing process. Abnormal expression of splicing factors may cause alterations in splicing events. Indeed, the expression levels of [11] . In some cases, splicing factors may become oncogenes or pseudo-oncogenes and can contribute to tumorigenesis [7] .
RNA-sequencing (RNA-seq) techniques and related bioinformatics methods could be used to identify cancer-related alternative splicing [12] . The Cancer Genome Atlas (TCGA) (https://portal.gdc.cancer.gov), supported by the US National Institutes of Health, contains an abundance of data on cancers, including RNA-seq data. SpliceSeq is a resource for RNA-
[13]. The protein-coding genes from the Ensemble database. The dataset of SpliceSeq contains seven alternative splicing patterns, namely, exon skip (ES), mutually exclusive exons (ME), retained intron (RI), alternate promoter (AP), alternate terminator (AT), alternate donor site (AD), and alternate acceptor site (AA) [4, 13] . The percent spliced-in index (PSI) value, ranging seven splicing patterns described above [14] . the splicing event and mRNA expression of its counterpart remains largely unclear. In events used for the construction of risk score (all) and the mRNA expression of corresponding the PSI value of the splicing event and mRNA the PSI value of the splicing event and mRNA expression of its counterpart gene.
Potential regulatory networks of SASEs between splicing factors and other genes
Splicing factors are RNA-binding proteins that regulate splicing events by recognizing increasing evidence has revealed varying, even opposing, functions of transcripts from the same genes from alternative splicing [9, [40] [41] [42] that ESRP1-ES-36041 may play different roles depending on its splicing targets. Also, the splicing factor of ESRP1 contained several SASEs, but the functions of these SASEs could 
